Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics

Cancer Research

Volumn 68, Issue 20, 2008, Pages 8278-8285

  Waalkes, Michael P ^a   Liu, Jie ^a   Germolec, Dori R ^a   Trempus, Carol S ^a   Cannon, Ronald E ^a   Tokar, Erik J ^a   Tennant, Raymond W ^a   Ward, Jerrold M ^b   Diwan, Bhalchandra A ^c  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Global VetPathology   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CD34 ANTIGEN; PHORBOL 13 ACETATE 12 MYRISTATE; RAC1 PROTEIN;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CANCER SUSCEPTIBILITY; CELL RENEWAL; CONTROLLED STUDY; FEMALE; FETUS; GENE ACTIVATION; GENE EXPRESSION; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE RAS; PAPILLOMA; PRENATAL EXPOSURE; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD34; ARSENIC; CARCINOMA, SQUAMOUS CELL; FEMALE; FETUS; GENES, RAS; MICE; NEOPLASTIC STEM CELLS; NEUROPEPTIDES; PREGNANCY; PROTEINS; RAC GTP-BINDING PROTEINS; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 54249136831     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2099     Document Type: Article

References (36)

1. Morley R. Fetal origins of adult disease. Semin Fetal Neonatal Med 2006;11:73-8.
2. Barker DJP. The origins of the developmental origins theory. J Intern Med 2007;261:412-7.
3. Dolinoy DC, Weidman JR, Jirtle RL. Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol 2007;23:297-307.
4. Anderson LM, Diwan BA, Fear NT, Roman E. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect 2000;108:573-94.
5. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res 2006;66:1883-90.
6. Clarke MF, Fuller M. Stem cells and cancer: two faces of Eve. Cell 2006;124:1111-5.
7. Kangsamaksin T, Park HJ, Trempus CS, Morris RJ. A perspective on murine keratinocyte stem cells as targets of chemically induced skin cancer. Mol Carcinog 2007;46:579-84.
8. Perez-Losada J, Balmain A. Stem cell hierarchy in skin cancer. Nat Rev Cancer 2003;3:434-43.
9. Waalkes MP, Liu J, Diwan BA. Transplacental arsenic carcinogenesis in mice. Toxicol Appl Pharmacol 2007;222:271-80.
10. Smith AH, Marshall G, Yuan Y, et al. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and early childhood. Environ Health Perspect 2006;114:1293-6.
11. Arsenic in drinking water. In: Some drinking water disinfectants and contaminants, including arsenic. International Agency for Researchon Cancer Monographs on the Evaluation of Carcinogenic Risk to Humans. vol. 84. Lyon: IARC Press; 2004. p. 269-477.
12. Germolec DR, Spalding J, Boorman GA, et al. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat Res 1997;386:209-18.
13. Germolec DR, Spalding J, Yu H-S, et al. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am J Pathol 1998;153:1775-85.
14. Rossman TG, Uddin AN, Burns FJ. Evidence that arsenic acts as a cocarcinogen in skin cancer. Toxicol Appl Pharmacol 2004;198:394-404.
15. Patterson TJ, Reznikova TV, Phillips MA, Rice RH. Arsenite maintains germinative state in cultured human epidermal cells. Toxicol Appl Pharmacol 2005;207:69-77.
16. Patterson TJ, Rice RH. Arsenite and insulin exhibit opposing effects on epidermal growth factor receptor and keratinocyte proliferative potential. Toxicol Appl Pharmacol 2007;221:119-28.
17. Humble MC, Trempus CS, Spalding JW, Cannon RE, Tennant RW. Biological, cellular, and molecular characteristics of an inducible transgenic skin tumor model: a review. Oncogene 2005;24:8217-28.
18. Trempus CS, Morris RJ, Ehinger M, et al. CD34 expression by hair follicle stem cells is required for skin tumor development in mice. Cancer Res 2007;67:4173-81.
19. Trempus CS, Morris RJ, Bortner CD, et al. Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34. J Invest Dermatol 2003;120:501-11.
20. Malanchi I, Peinado H, Kassen D, et al. Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling. Nature 2008;452:650-3.
21. Cardiff RD, Leder A, Kuo A, Pattengale PK, Leder P. Multiple tumor types appear in transgenic mouse with the RAS oncogene. Am J Pathol 1993;142:1199-207.
22. Hansen LA, Trempus CS, Mahler JF, Tennant RW. Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg AC mice. Carcinogenesis 1996;17:1825-33.
23. Darwiche N, Ryscavage A, Perez-Lorenzo R, et al. Expression profile of skin papilloma with high cancer risk displays a unique genetic signature with squamous cell carcinomas and predicts for malignant conversion. Oncogene 2007;26:6885-95.
24. Glick A, Ryscavage A, Perez-Lorenzo R, et al. The high-risk benign tumor: evidence from two stage skin cancer model and relevance for human cancer. Mol Carcinog 2007;46:605-10.
25. Gerdes MJ, Yuspa SH. The contribution of epidermal stem cells to skin cancer. Stem Cell Rev 2005;1:225-32.
26. Cannon RE, Spalding JW, Virgil KM, et al. Induction of transgene expression in Tg.AC(v-Ha-ras) transgenic mice concomitant with DNA hypomethylation. Mol Carcinog 1998;21:244-50.
27. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Nat Acad Sci U S A 1997;94:10907-12.
28. Benitah SA, Frye M, Glogauer M, Watt FM. Stem cell depletion through epidermal deletion of rac1. Science 2005;309:933-5.
29. Kwei KA, Finch JS, Ranger-Moore J, Bowden GT. The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells. Cancer Lett 2006;231:326-38.
30. Arnold I, Watt FM. c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr Biol 2001;11:558-68.
31. Straub AC, Stolz DB, Ross MA, et al. Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver. Hepatology 2007;45:205-12.
32. Wei S-J, Trempus CS, Cannon RE, Bortner CD, Tennant RW. Identification of Dss1 as a 12-O-tetradecanoylphorbol-13-acetate-responsive gene expressed in keratinocyte progenitor cells, withpossible involvement in early skin tumorigenesis. J Biol Chem 2003;278:1758-68.
33. Dang H, Trempus C, Malarkey DE, et al. Identification of genes and gene ontology processes critical to skin papilloma development in Tg AC transgene mice. Mol Carcinog 2006;45:126-40.
34. Beachy PA, Karhadkar SS, Berman BM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004;432:324-31.
35. Gardner RL. Stem cells and regenerative medicine: principles, prospects and problems. C R Biol 2007;330:465-73.
36. Smith GH, Chepko G. Mammary epithelial stem cells. Microsc Res Tech 2001;52:190-203.